ArticleBlood advances2019
Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone.
Efstathios Kastritis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this paperpooled ittrialcites it